Newly updated stroke prevention guidelines from the American Heart Association and American Stroke Association say women with endometriosis and women with early-onset menopause are at greater risk.
A group of investigators led by Cedars-Sinai have developed and successfully tested a new artificial intelligence (AI) method to make launching cancer clinical trials easier and faster.
La influenza puede ser una enfermedad desagradable de una semana de duración y un inconveniente para muchas personas, pero puede tener consecuencias graves para los adultos mayores.
The flu might be a miserable weeklong illness and inconvenience for many people, but it can have serious consequences for older adults.
Cedars-Sinai has published a summary highlighting its research advances for November 2024.
Cedars-Sinai’s Center for Medicine, Holocaust and Genocide Studies, in cooperation with the peer-reviewed medical journal The Lancet, will host a free event, open to the public, focusing on how the history of medicine, Nazism and the Holocaust is influencing the practice, students and practitioners of today’s health professions.
Cedars-Sinai investigators are one step closer to manufacturing stem cells in space, which could speed up the development of new medical therapies on Earth. The first published data from the experiments conducted on a private space mission appeared in the peer-reviewed Nature portfolio journal NPJ Microgravity.
Physicians and investigators from the Smidt Heart Institute at Cedars-Sinai will give more than 30 presentations at the American Heart Association (AHA) Scientific Sessions Nov. 16-18 in Chicago.
In an effort to foster economic growth throughout Southern California’s diverse communities, Cedars-Sinai has taken a lead role in creating a first-of-its-kind centralized resource directory designed to help diverse-owned vendors secure business opportunities with Southern California hospitals.
Taking antibiotics during an influenza infection can be harmful and increases the risk of developing a bacterial pneumonia while sick with the flu, according to new research led by Cedars-Sinai.
Según un nuevo estudio dirigido por Cedars-Sinai, un porcentaje de hombres estadounidenses de edad avanzada con cáncer de próstata de riesgo intermedio y alto se someten a tratamientos que conllevan riesgos de efectos secundarios que pueden reducir significativamente la calidad de vida sin prolongarla.
Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality of life without extending life, according to a new study led by Cedars-Sinai.
Cedars-Sinai has appointed prominent inflammatory bowel disease physician-scientist Maria T. Abreu, MD, to be the executive director of the F. Widjaja Inflammatory Bowel Disease Institute. Abreu will succeed longstanding director Stephan Targan, MD, her mentor and a former research colleague from more than two decades ago.
Cedars-Sinai Guerin Children’s is building a formidable pediatric research enterprise aimed at identifying the genetic underpinnings of childhood diseases and developing novel therapies.
Experts on healthy aging from Cedars-Sinai’s growing Center for Translational Geroscience and Geriatrics Program will present their latest research and clinical advances at The Gerontological Society of America’s (GSA) 2024 Annual Scientific Meeting in Seattle, Nov. 13-16.
Ivan Vujkovic-Cvijin, PhD, is a pioneer in the study of the gut microbiota and the surprising ways these microorganisms living in our digestive tracts affect our overall health. His discoveries have been featured in Nature, Science Translational Medicine, Cell Reports and other top scientific journals.
Cedars-Sinai has earned the highest level of recognition from the College of Healthcare Information Management Executives (CHIME) as part of its annual Digital Health Most Wired (DHMW) Survey, which evaluates the technological capabilities of healthcare organizations.
Cedars-Sinai is expanding its long-standing commitment to local nonprofits through grantmaking and shared learning opportunities, as a way to promote greater health equity in the areas of homelessness and housing, access to care, and other community response categories.
New research led by Cedars-Sinai investigators has reversed liver fibrosis, a gradual buildup of scar tissue in the liver, in laboratory mice. Their achievement marks a crucial step toward potentially creating new treatments for patients with this condition, which can lead to life-threatening diseases including cirrhosis, liver failure and liver cancer.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
